Five years of EMA-approved systemic cancer therapies for solid tumours:a comparison of two thresholds for meaningful clinical benefit

Autor: Katharina Rosian, Sarah Wolf, Nicole Grössmann, Richard Sullivan, J.C. Del Paggio, Robert Emprechtinger, Claudia Wild, Christopher M. Booth
Jazyk: angličtina
Rok vydání: 2017
Předmět:
Zdroj: Grössmann, N, Del Paggio, J C, Wolf, S, Sullivan, R, Booth, C M, Rosian, K, Emprechtinger, R & Wild, C 2017, ' Five years of EMA-approved systemic cancer therapies for solid tumours : a comparison of two thresholds for meaningful clinical benefit ', European Journal of Cancer, vol. 82, pp. 66-71 . https://doi.org/10.1016/j.ejca.2017.05.029
Brücken bauen-von der Evidenz zum Patientenwohl; 19. Jahrestagung des Deutschen Netzwerks Evidenzbasierte Medizin; 20180308-20180310; Graz, Österreich; DOC18ebmV-07-2 /20180306/
Popis: Objective: Several societies have proposed frameworks that attempt to support the optimal use of limited health care resources, while offering a standardised and transparent tool to evaluate the benefit of novel cancer therapies. One prominent tool is the European Society for Medical Oncology Magnitude[for full text, please go to the a.m. URL]
Brücken bauen – von der Evidenz zum Patientenwohl; 19. Jahrestagung des Deutschen Netzwerks Evidenzbasierte Medizin
Databáze: OpenAIRE